Annual Short Term Debt
$34.60 K
+$18.00 K+108.43%
31 December 2023
Summary:
BioNexus Gene Lab annual short term debt is currently $34.60 thousand, with the most recent change of +$18.00 thousand (+108.43%) on 31 December 2023. During the last 3 years, it has fallen by -$11.10 thousand (-24.29%). BGLC annual short term debt is now -24.29% below its all-time high of $45.70 thousand, reached on 01 December 2020.BGLC Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$48.20 K
-$5000.00-9.40%
30 September 2024
Summary:
BioNexus Gene Lab quarterly short term debt is currently $48.20 thousand, with the most recent change of -$5000.00 (-9.40%) on 30 September 2024. Over the past year, it has increased by +$14.30 thousand (+42.18%). BGLC quarterly short term debt is now -9.40% below its all-time high of $53.20 thousand, reached on 30 June 2024.BGLC Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGLC Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +108.4% | +42.2% |
| 3 y3 years | -24.3% | +22.0% |
| 5 y5 years | +81.2% | - |
BGLC Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -24.3% | +108.4% | -9.4% | +308.5% |
| 5 y | 5 years | -24.3% | +108.4% | -9.4% | +308.5% |
| alltime | all time | -24.3% | +108.4% | -9.4% | +308.5% |
BioNexus Gene Lab Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $48.20 K(-9.4%) |
| June 2024 | - | $53.20 K(+63.7%) |
| Mar 2024 | - | $32.50 K(-6.1%) |
| Dec 2023 | $34.60 K(+108.4%) | $34.60 K(+2.1%) |
| Sept 2023 | - | $33.90 K(+110.6%) |
| June 2023 | - | $16.10 K(-3.6%) |
| Mar 2023 | - | $16.70 K(+0.6%) |
| Dec 2022 | $16.60 K(-58.0%) | $16.60 K(+40.7%) |
| Sept 2022 | - | $11.80 K(-15.7%) |
| June 2022 | - | $14.00 K(-62.6%) |
| Mar 2022 | - | $37.40 K |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $39.50 K(-13.6%) | - |
| Dec 2021 | - | $39.50 K(0.0%) |
| Sept 2021 | - | $39.50 K(-1.0%) |
| June 2021 | - | $39.90 K(+0.8%) |
| Mar 2021 | - | $39.60 K(-13.3%) |
| Dec 2020 | $45.70 K(+42.4%) | $45.70 K(+47.4%) |
| Sept 2020 | - | $31.00 K(+0.3%) |
| June 2020 | - | $30.90 K(+60.9%) |
| Mar 2020 | - | $19.20 K(-40.2%) |
| Dec 2019 | $32.10 K(+68.1%) | $32.10 K |
| Dec 2018 | $19.10 K | - |
FAQ
- What is BioNexus Gene Lab annual short term debt?
- What is the all time high annual short term debt for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual short term debt year-on-year change?
- What is BioNexus Gene Lab quarterly short term debt?
- What is the all time high quarterly short term debt for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly short term debt year-on-year change?
What is BioNexus Gene Lab annual short term debt?
The current annual short term debt of BGLC is $34.60 K
What is the all time high annual short term debt for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual short term debt is $45.70 K
What is BioNexus Gene Lab annual short term debt year-on-year change?
Over the past year, BGLC annual short term debt has changed by +$18.00 K (+108.43%)
What is BioNexus Gene Lab quarterly short term debt?
The current quarterly short term debt of BGLC is $48.20 K
What is the all time high quarterly short term debt for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly short term debt is $53.20 K
What is BioNexus Gene Lab quarterly short term debt year-on-year change?
Over the past year, BGLC quarterly short term debt has changed by +$14.30 K (+42.18%)